RecruitingPHASE1, PHASE2NCT04901702
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Studying Hepatoblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St. Jude Children's Research Hospital
- Principal Investigator
- Sara Federico, MD, M.DSt. Jude Children's Research Hospital
- Intervention
- Onivyde(drug)
- Enrollment
- 90 enrolled
- Eligibility
- 30 years · All sexes
- Timeline
- 2021 – 2026
Study locations (10)
- Lucille Packard Children's Hospital Stanford, Palo Alto, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta, Georgia, United States
- Children's Hospital and Clinics of Minn, Minneapolis, Minnesota, United States
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
- Texas Children's Hospital/ Baylor College of Medicine, Houston, Texas, United States
- The Hospital for Sick Children, Toronto, Ontario, Canada
- CHU Sainte-Justine, Montreal, Canada
- BC Children's Hospital Research Institute, Vancouver, Canada
Collaborators
Pfizer · Ipsen
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04901702 on ClinicalTrials.govOther trials for Hepatoblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07188311Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in ChildrenSun Yat-sen University
- RECRUITINGNCT05556642Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium InitiativeChildren's Hospital Medical Center, Cincinnati
- RECRUITINGPHASE1, PHASE2NCT04634357ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular CarcinomaEureka Therapeutics Inc.
- RECRUITINGPHASE2NCT07300449A Prospective Multicenter Clinical Study of SCCG Protocol and ctDNA 5hmc in Predicting the Chemotherapy Sensitivity and Monitoring the Recurrence and Metastasis of Hepatoblastoma in Children and AdolescentsSun Yat-sen University
- RECRUITINGPHASE3NCT04478292A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT StrategyShanghai Children's Medical Center
- ACTIVE NOT RECRUITINGPHASE3NCT03017326Paediatric Hepatic International Tumour TrialUniversity of Birmingham
- ACTIVE NOT RECRUITINGPHASE3NCT00980460Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver CancerNational Cancer Institute (NCI)